Mark J. Gabrielson President & Chief Executive Officer, Ore Pharmaceutical Holdings Inc. (NASD: ORXE)
Dr. Klibanov is currently Professor of Chemistry and Bioengineering at the Massachusetts Institute of Technology. His research interests include enzyme chemistry and biotechnology, protein drug delivery and formulation, stability and stabilization of pharmaceutical proteins, and biochemistry in extreme environments. Professor Klibanov has authored over 230 scientific papers and 15 issued U.S. patents and is a member of seven journal editorial boards. He has received numerous prestigious awards including the Leo Friend Award, the Ipatieff Prize, the Marvin J. Johnson Award, and the Arthur C. Cope Scholar Award from the American Chemical Society, as well as the International Enzyme Engineering Prize. He was elected to the National Academy of Sciences and to the National Academy of Engineering of the United States. In addition, Dr. Klibanov has started several biotechnology companies and has been a scientific advisor/consultant for numerous pharmaceutical and chemical companies.